Caffeic Acid Inhibits Tumour Mass Formation in MG-63 Cells-induced Nude Mice

Ferry Sandra, Dewi Ranggaini, Laifa Annisa Hendarmin, Nurrani Mustika Dewi, Melanie Sadono Djamil


BACKGROUND: Formation of tumour mass is one symptom of osteosarcoma development. Caffeic acid has been known to provide effective treatment but has less side effect for some cancer therapy. Studies reported that caffeic acid might promote apoptosis in MG-63 osteosarcoma cells, however, the effect of caffeic acid treatment in preventing tumour mass formation has not been well elucidated, especially in MG-63 cells-induced nude mice in vivo.

METHODS: MG-63 cells were pre-treated with 0, 1, or 10 µg/mL caffeic acid, and 6 hours after pre-treatment, MG-63 cells were injected into subcutaneous space of mice to induce osteosarcoma. Another model was also created by subcutaneously injecting MG-63 cells to the back of mice, and after 48 days, the visible tumour mass was injected intra-tumour with 0 or 10 µg/mL caffeic acid every 7 days for 6 times. After 90 days, mice were anaesthetised, and the nodule pictures were taken for observation and measurement.

RESULTS: In pre-treated MG-63 cells-induced mice, volumes of the mass decreased in reverse with the dose of caffeic acid given. Ten µg/mL caffeic acid pre-treatment was able to significantly lower the mass volume compared to the untreated (p<0.05). Meanwhile, the intra-tumour treatment of 10 µg/mL caffeic acid, even though not significant, was able to inhibit tumour mass formation.

CONCLUSION: Results of caffeic acid pre-treatment and caffeic acid treatment in tumour mass of mice show that caffeic acid is able to inhibit the MG-63 cells formation. This suggests that caffeic acid can be a potential anti-cancer agent.

KEYWORDS: caffeic acid, osteosarcoma, MG-63 cells, tumour mass

Full Text:



Savvidou O, Papakonstantinou O, Lakiotaki E, Zafeiris I, Melissaridou D, Korkolopoulou P, et al. Surface bone sarcomas: an update on current clinicopathological diagnosis and treatment. EFORT Open Reviews. 2021; 6(10): 905-17, CrossRef.

Vormoor B, Knizia HK, Batey MA, Almeida GS, Wilson I, Dildey P, et al. Development of a preclinical orthotopic xenograft model of ewing sarcoma and other human malignant bone disease using advanced in vivo imaging. PLoS ONE. 2014; 9(1): e85128, CrossRef.

Sandra F, Rizal MI, Wahid AHA, Andajana M, Celinna M. Caffeic acid induces intrinsic apoptotic pathway in mg-63 osteosarcoma cells through bid truncation and cytochrome c release. Indones Biomed J. 2022; 14(3): 323-8, CrossRef.

Wittig JC, Kellar-Graney K, Shmookler B. Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician. 2002; 65(6): 1123-32, PMID.

Su LJ, Fiehn O, Maruvada P, Moore SC, O’Keefe SJ, Wishart DS, et al. The use of metabolomics in population-based research123. Adv Nutr. 2014; 5(6): 785-8, CrossRef.

Martella E, Dozza B, Ferroni C, Obeyok CO, Guerrini A, Tedesco D, et al. Two beats one: osteosarcoma therapy with light-activated and chemo-releasing keratin nanoformulation in a preclinical mouse model. Pharmaceutics. 2022; 14(3): 677, CrossRef.

Sandra F, Sidharta MA. Caffeic acid induced apoptosis in MG63 osteosarcoma cells through activation of caspases. Mol Cell Biomed Sci. 2017; 1(1): 28-33, CrossRef.

Wang T, Gong X, Jiang R, Li H, Du W, Kuang G. Ferulic acid inhibits proliferation and promotes apoptosis via blockage of PI3K/Akt pathway in osteosarcoma cell. Am J Transl Res. 2016; 8(2): 968-80, PMID.

Dziedzic A, Kubina R, Kabała-Dzik A, Tanasiewicz M. Induction of cell cycle arrest and apoptotic response of head and neck squamous carcinoma cells (detroit 562) by caffeic acid and caffeic acid phenethyl ester derivative. Evid-based Complement Altern Med. 2017; 2017: 6793456, CrossRef.

Girsang E, Lister INE, Ginting CN, Bethasari M, Amalia A, Widowati W. Comparison of antiaging and antioxidant activities of protocatechuic and ferulic acids. Mol Cell Biomed Sci. 2020; 4(2): 68-75, CrossRef.

Sandra F, Hudono KF, Putri AA, Putri CAP. Caspase inhibitor diminishes caffeic acid-induced apoptosis in osteosarcoma cells. Indones Biomed J. 2017; 9(3): 160-4, CrossRef.

Son KD, Kim YJ. Anticancer activity of drug-loaded calcium phosphate nanocomposites against human osteosarcoma. Biomater Res. 2017; 21(1): 13, CrossRef.

Nardini M, Cirillo E, Natella F, Scaccini C. Absorption of phenolic acids in humans after coffee consumption. J Agric Food Chem. 2002; 50(20): 5735-41, CrossRef.

Tapiero H, Tew KD, Nguyen Ba G, Mathé G. Polyphenols: do they play a role in the prevention of human pathologies? Biomedicine & Pharmacotherapy. 2002; 56(4): 200-7, CrossRef.

Sandra F, Ketherin K. Caffeic acid inhibits RANKL and TNF-α-induced phosphorylation of p38 mitogen-activated protein kinase in RAW-D cells. Indones Biomed J. 2018; 10(2): 140-3, CrossRef.

Euhus DM, Hudd C, Laregina MC, Johnson FE. Tumor measurement in the nude mouse. J Surg Oncol. 1986; 31(4): 229-34, CrossRef.

Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol. 1989; 24(3): 148-54, CrossRef.

Udagawa T, Fernandez A, Achilles E, Folkman J, D’Amato RJ. Persistence of microscopic human cancers in mice: alterations in the angiogenic balance accompanies loss of tumor dormancy. FASEB J. 2002; 16(11): 1361-70, CrossRef.

Zhu W, Guo F, Xu T, Chen A. Establishment of nude mice model of human osteosarcoma cell MG63 with different potential of metastasis. Chinese German J Clin Oncol. 2007; 6(5): 484-6, CrossRef.

Yamanaka D, Tajima K, Adachi Y, Ishibashi K ichi, Miura NN, Motoi M, et al. Effect of polymeric caffeic acid on antitumour activity and natural killer cell activity in mice. J Funct Foods. 2014; 6: 513-22, CrossRef.

Koru Ö, Avcu F, Tanyüksel M, Ural AU, Araz RE, Şener K. Cytotoxic effects of caffeic acid phenethyl ester (CAPE) on the human multiple myeloma cell line. Turk J Med Sci. 2009; 39(6): 863-70, CrossRef.

Magnani C, Isaac VLB, Correa MA, Salgado HRN. Caffeic acid: a review of its potential use in medications and cosmetics. Anal Methods. 2014; 6(10): 3203-10, article.

Omene CO, Wu J, Frenkel K. Caffeic acid phenethyl ester (CAPE) derived from propolis, a honeybee product, inhibits growth of breast cancer stem cells. Invest New Drugs. 2012; 30(4): 1279-88, CrossRef.

Orsolic N, Tadic Z, Alcici NMF, Brbot-Saranovic A, Bendelja K, Krsnik B, et al. Antimetastatic effects of propolis, caffeic acid phenethyl ester and caffeic acid on mammary carcinoma of CBAmouse. 17th international Cancer Congress, Rio de Janeiro 1998 August 24-28. Bologna: Monduzzi Editore; 1998, article.

Lauvrak SU, Munthe E, Kresse SH, Stratford EW, Namløs HM, Meza-Zepeda LA, et al. Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. Br J Cancer. 2013; 109(8): 2228-36, CrossRef.


Copyright (c) 2022 The Prodia Education and Research Institute

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


Indexed by:






The Prodia Education and Research Institute